SCHEMBL4438430

SCHEMBL4438430

O=C(NC1(C(=O)OCC2c3ccccc3-c3ccccc32)CCN(C(=O)OCC2c3ccccc3-c3ccccc32)CC1)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
DPP8 Q6V1X1 1/20 0.46
DPP9 Q86TI2 1/20 0.46
EPHX2 P34913 1/20 0.44
OPRD1 P41143 1/20 0.38
MDM4 O15151 1/20 0.38
TP53 P04637 1/20 0.38
CASP3 P42574 2/20 0.38
FABP7 O15540 1/20 0.38
FABP5 Q01469 1/20 0.38
POLB P06746 1/20 0.38
TSHR P16473 1/20 0.37
BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1404235 0.91 EPHX2 (0.46) KMT2ADPP8DPP9EPHX2OPRD1
SCHEMBL3491022 0.90 DPP8 (0.47) KMT2ADPP8DPP9EPHX2OPRD1
SCHEMBL31515070 0.86 BACE1 (0.46) KMT2ADPP8DPP9EPHX2TSHR
SCHEMBL5192807 0.86 BACE1 (0.46) KMT2ADPP8DPP9EPHX2TSHR
SCHEMBL3088791 0.85 KMT2A (0.44) KMT2ADPP8DPP9EPHX2OPRD1
SCHEMBL3088787 0.85 SMN1; SMN2 (0.46) KMT2ADPP8DPP9EPHX2OPRD1
SCHEMBL6111714 0.84 EPHX2 (0.46) KMT2ADPP8DPP9EPHX2OPRD1
SCHEMBL12644793 0.83 KMT2A (0.52) KMT2ADPP8DPP9EPHX2MDM4
SCHEMBL3489481 0.83 DPP8 (0.42) KMT2ADPP8DPP9EPHX2OPRD1
SCHEMBL2414478 0.82 BACE1 (0.41) KMT2ADPP8DPP9EPHX2OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125805-A1 SUBSTITUTED PIPERIDINES HAVING PROTEIN KINASE INHIBITING ACTIVITY Astex Therapeutics Limited (GB) 2009-12-02 EP disclosed
WO-2008075109-A1 SUBSTITUTED PIPERIDINES HAVING PROTEIN KINASE INHIBITING ACTIVITY ASTEX THERAPEUTICS LIMITED (GB) 2008-06-26 WO disclosed